Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLACIER: Implementation of CABENUVA in Infusion Centers
NCT04982445Phase 4Completed
- Sponsor
- ViiV Healthcare
- Start
- Nov 2021
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cabotegravir + rilpivirine in human immunodeficiency virus infection (HIV), sponsored by ViiV Healthcare. Started Nov 2021; status: completed.
02
Drugs
cabotegravir + rilpivirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT04982445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04982445.